Evolent Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on November 17, 2017. The report addresses a corporate governance event involving the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a personnel change and does not contain financial performance data.
Material Changes
On November 17, 2017, Michael Kirshbaum resigned from the Board of Directors. Mr. Kirshbaum was originally appointed by The Advisory Board Company under a Stockholders Agreement dated June 4, 2015. His resignation was directly connected to the completion of the acquisition of The Advisory Board Company by OptumInsight, Inc., a wholly owned subsidiary of UnitedHealth Group Incorporated, on the same date.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, or specific risk factors beyond the context of the acquisition triggering the director's departure.
Key Facts for Investor Verification
- Michael Kirshbaum resigned from the Board of Directors on November 17, 2017.
- The resignation resulted from the acquisition of The Advisory Board Company by OptumInsight, Inc. (UnitedHealth Group).
- The report does not disclose any financial results or changes in the company's capital structure.